750 related articles for article (PubMed ID: 10834863)
41. A correlation between knee cartilage degradation observed by arthroscopy and synovial proteinases activities.
Marini S; Fasciglione GF; Monteleone G; Maiotti M; Tarantino U; Coletta M
Clin Biochem; 2003 Jun; 36(4):295-304. PubMed ID: 12810159
[TBL] [Abstract][Full Text] [Related]
42. The Expression of Inflammasomes NLRP1 and NLRP3, Toll-Like Receptors, and Vitamin D Receptor in Synovial Fibroblasts From Patients With Different Types of Knee Arthritis.
Sakalyte R; Denkovskij J; Bernotiene E; Stropuviene S; Mikulenaite SO; Kvederas G; Porvaneckas N; Tutkus V; Venalis A; Butrimiene I
Front Immunol; 2021; 12():767512. PubMed ID: 35126351
[TBL] [Abstract][Full Text] [Related]
43. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
[TBL] [Abstract][Full Text] [Related]
44. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis.
Clark IM; Powell LK; Ramsey S; Hazleman BL; Cawston TE
Arthritis Rheum; 1993 Mar; 36(3):372-9. PubMed ID: 8452582
[TBL] [Abstract][Full Text] [Related]
45. Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients.
Lee YA; Kim JY; Hong SJ; Lee SH; Yoo MC; Kim KS; Yang HI
Clin Rheumatol; 2007 Dec; 26(12):2023-2029. PubMed ID: 17393234
[TBL] [Abstract][Full Text] [Related]
46. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
[TBL] [Abstract][Full Text] [Related]
47. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.
Maeda S; Sawai T; Uzuki M; Takahashi Y; Omoto H; Seki M; Sakurai M
Ann Rheum Dis; 1995 Dec; 54(12):970-5. PubMed ID: 8546529
[TBL] [Abstract][Full Text] [Related]
48. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
49. Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3.
Koskinen A; Vuolteenaho K; Moilanen T; Moilanen E
Scand J Rheumatol; 2014; 43(3):249-53. PubMed ID: 24780007
[TBL] [Abstract][Full Text] [Related]
50. Elastase activity in cartilage extracts and synovial fluids from subjects with osteoarthritis or rheumatoid arthritis: the prominent role of metalloproteinases.
Chevalier X; Groult N; Texier JM; Larget-Piet B; Hornebeck W
Clin Exp Rheumatol; 1996; 14(3):235-41. PubMed ID: 8809436
[TBL] [Abstract][Full Text] [Related]
51. Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.
Connolly M; Mullan RH; McCormick J; Matthews C; Sullivan O; Kennedy A; FitzGerald O; Poole AR; Bresnihan B; Veale DJ; Fearon U
Arthritis Rheum; 2012 Apr; 64(4):1035-45. PubMed ID: 22076945
[TBL] [Abstract][Full Text] [Related]
52. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
53. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections.
Kanangat S; Postlethwaite A; Hasty K; Kang A; Smeltzer M; Appling W; Schaberg D
Arthritis Res Ther; 2006; 8(6):R176. PubMed ID: 17129374
[TBL] [Abstract][Full Text] [Related]
54. Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis.
Chen JR; Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
J Rheumatol; 1998 Dec; 25(12):2440-4. PubMed ID: 9858442
[TBL] [Abstract][Full Text] [Related]
55. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
56. Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
Thwin MM; Douni E; Arjunan P; Kollias G; Kumar PV; Gopalakrishnakone P
Arthritis Res Ther; 2009; 11(5):R138. PubMed ID: 19765281
[TBL] [Abstract][Full Text] [Related]
57. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis.
Naito K; Takahashi M; Kushida K; Suzuki M; Ohishi T; Miura M; Inoue T; Nagano A
Rheumatology (Oxford); 1999 Jun; 38(6):510-5. PubMed ID: 10402070
[TBL] [Abstract][Full Text] [Related]
58. Differential Expression of Renin-Angiotensin System-related Components in Patients with Rheumatoid Arthritis and Osteoarthritis.
Wu Y; Li M; Zeng J; Feng Z; Yang J; Shen B; Zeng Y
Am J Med Sci; 2020 Jan; 359(1):17-26. PubMed ID: 31785770
[TBL] [Abstract][Full Text] [Related]
59. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
60. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.
Kokebie R; Aggarwal R; Lidder S; Hakimiyan AA; Rueger DC; Block JA; Chubinskaya S
Arthritis Res Ther; 2011 Mar; 13(2):R50. PubMed ID: 21435227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
